Just one more thought...I promise!

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

PVLee

Rank: Mail Room [?]

Points: 183 [?]

Votes: 1 Score: 3.0 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Just one more thought...I promise!

posted on Dec 11, 2015 01:59PM

DM said they "May also wind up spinning out other companies for different indications." Just assume for a minute that this proposal is passed in January. Also assume for a minute that the new Zenith Capital Corp.spins out Newco in the same manner as RVX Therapeutics was to create Zenith Epiginetics Corp. in 2013. Now if ZCC decides to go public it's going to cost anyone wanting to get on this train big time. Think about it. PVLee

2 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply